awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q59126618-5DF8926B-ED00-48B6-A80B-9782AE0D9439
Q59126618-5DF8926B-ED00-48B6-A80B-9782AE0D9439
BestRank
Statement
http://www.wikidata.org/entity/statement/Q59126618-5DF8926B-ED00-48B6-A80B-9782AE0D9439
Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1
P2860
Q59126618-5DF8926B-ED00-48B6-A80B-9782AE0D9439
BestRank
Statement
http://www.wikidata.org/entity/statement/Q59126618-5DF8926B-ED00-48B6-A80B-9782AE0D9439
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d866aeff0c283b5eba7f904a1f7283606e6044c5
P2860
A phase I/II study of the pan Bcl-2 inhibitor obatoclax mesylate plus bortezomib for relapsed or refractory mantle cell lymphoma.